Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-7912 plus modified FOLFIRINOX in previously treated pancreatic cancer
jRCT2080225264Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of devimistat in pancreatic adenocarcinoma (PDAC), sponsored by Ono Pharmaceutical. Started Jul 2020; status: completed.
02
Drugs
devimistat
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on jRCT2080225264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225264.